Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate-MedSci.cn

Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate

Wang, JY; Yu, GP; Li, L; Lin, GW; Ye, DW

Lin, GW; Ye, DW (通讯作者)，Fudan Univ, Dept Urol, Shanghai Canc Ctr, 270 Dongan Rd, Shanghai 200032, Peoples R China.

MILITARY MEDICAL RESEARCH, 2022; 9 (1):

科室
- - 订阅+
  - 更多科室
工具
服务